Does Intermuscular Adipose Tissue (IMAT) Promote Muscle Insulin Resistance and Sarcopenia?

Symposium — Wednesday, April 28, 2021 — 4:00 PM - 5:30 PM — Virtual Session, Room APS-4
American Federation for Medical Research (AFMR) — Chair: Bryan Bergman — Co-Chair: Lauren Sparks

Attendees will be able to understand that intermuscular adipose tissue is a unique adipose depot with a significant role in metabolic health. Learning objectives: 1) Not all adipose tissue depots are created equally; 2) Intermuscular adipose tissue (IMAT) in particular is an understudied organ that could potentially serve as a therapeutic target in obesity, diabetes and sarcopenia; and 3)Potential mechanisms linking IMAT content with cardiovascular disease and metabolic health.

Speakers

• Introduction
  Bryan Bergman — Endocrinology, University of Colorado, Anschutz Medical Campus
  4:00 PM - 4:05 PM


• How Bad Can It Be? Comparing IMAT to Subcutaneous and Visceral Adipose Tissue in Humans
  Bryan Bergman — Endocrinology, University of Colorado, Anschutz Medical Campus
  4:05 PM - 4:45 PM


• Profiling Human Adipose Progenitor Cells from Intermuscular vs. Abdominal Subcutaneous Depots
  Lauren Sparks — Translational Research Institute - Advent Health
  4:45 PM - 5:25 PM


• Conclusion
  Bryan Bergman — Endocrinology, University of Colorado, Anschutz Medical Campus
  5:25 PM - 5:30 PM